I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Wilson, Zena
70
results:
Search for persons
X
Format
Online (70)
Mediatypes
E-Books (1)
Articles (Online) (29)
Bookchapter (Online) (2)
OpenAccess-fulltext (38)
Languages
english (59)
spanish (1)
Sorted by: Relevance
Sorted by: Year
?
1
The ATR inhibitor ceralasertib potentiates cancer checkpoin..:
Hardaker, Elizabeth L.
;
Sanseviero, Emilio
;
Karmokar, Ankur
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
Relevance of ATM Status in Driving Sensitivity to DNA Damag..:
Karmokar, Ankur
;
Sargeant, Rebecca
;
Hughes, Adina M.
...
Cancers. 15 (2023) 16 - p. 4195 , 2023
Link:
https://doi.org/10.3390/..
?
3
Identification of a Molecularly-Defined Subset of Breast an..:
Serra, Violeta
;
Wang, Anderson T.
;
Castroviejo-Bermejo, Marta
...
Clinical Cancer Research. 28 (2022) 20 - p. 4536-4550 , 2022
Link:
https://doi.org/10.1158/..
?
4
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activ..:
Wilson, Zena
;
Odedra, Rajesh
;
Wallez, Yann
...
Cancer Research. 82 (2022) 6 - p. 1140-1152 , 2022
Link:
https://doi.org/10.1158/..
?
5
PARP inhibition is a modulator of anti-tumor immune respons..:
Staniszewska, Anna D.
;
Armenia, Joshua
;
King, Matthew
...
OncoImmunology. 11 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1080/..
?
6
Combined PARP and ATR inhibition potentiates genome instabi..:
Lloyd, Rebecca L.
;
Wijnhoven, Paul W. G.
;
Ramos-Montoya, Antonio
...
Oncogene. 39 (2020) 25 - p. 4869-4883 , 2020
Link:
https://doi.org/10.1038/..
?
7
A multi-batch design to deliver robust estimates of efficac..:
Karp, Natasha A.
;
Wilson, Zena
;
Stalker, Eve
...
Scientific Reports. 10 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
8
Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glut..:
Finlay, M. Raymond V.
;
Anderton, Mark
;
Bailey, Andrew
...
Journal of Medicinal Chemistry. 62 (2019) 14 - p. 6540-6560 , 2019
Link:
https://doi.org/10.1021/..
?
9
An innovative non-invasive technique for subcutaneous tumou..:
Delgado-SanMartin, Juan
;
Ehrhardt, Beate
;
Paczkowski, Marcin
...
PLOS ONE. 14 (2019) 10 - p. e0216690 , 2019
Link:
https://doi.org/10.1371/..
?
10
Discovery and Characterization of AZD6738, a Potent Inhibit..:
Foote, Kevin M.
;
Nissink, J. Willem M.
;
McGuire, Thomas
...
Journal of Medicinal Chemistry. 61 (2018) 22 - p. 9889-9907 , 2018
Link:
https://doi.org/10.1021/..
?
11
pRAD50: a novel and clinically applicable pharmacodynamic b..:
Jones, Gemma N.
;
Rooney, Claire
;
Griffin, Nicola
...
British Journal of Cancer. 119 (2018) 10 - p. 1233-1243 , 2018
Link:
https://doi.org/10.1038/..
?
12
CXCR2 Inhibition Profoundly Suppresses Metastases and Augme..:
Steele, Colin W.
;
Karim, Saadia A.
;
Leach, Joshua D.G.
...
Cancer Cell. 29 (2016) 6 - p. 832-845 , 2016
Link:
https://doi.org/10.1016/..
?
13
PDGFR Inhibition Results in Pericyte Depletion and Hemorrha..:
Hall, Anthony P.
;
Ashton, Susan
;
Horner, Judith
...
Toxicologic Pathology. 44 (2015) 1 - p. 98-111 , 2015
Link:
https://doi.org/10.1177/..
?
14
Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluor..:
De Savi, Chris
;
Bradbury, Robert H.
;
Rabow, Alfred A.
...
Journal of Medicinal Chemistry. 58 (2015) 20 - p. 8128-8140 , 2015
Link:
https://doi.org/10.1021/..
?
15
Correlation of MRI Biomarkers with Tumor Necrosis in Hras5 ..:
Bradley, Daniel P.
;
Tessier, Jean J.
;
Ashton, Susan E.
...
Neoplasia. 9 (2007) 5 - p. 382-391 , 2007
Link:
https://doi.org/10.1593/..
1-15